首页> 外文OA文献 >Molecular and structural characterization of the L1 virus-like particles that are used as vaccine antigens inCervarix™, the AS04-adjuvanted HPV-16 and -18 cervical cancer vaccine

【2h】

Molecular and structural characterization of the L1 virus-like particles that are used as vaccine antigens inCervarix™, the AS04-adjuvanted HPV-16 and -18 cervical cancer vaccine

机译：L1病毒样颗粒的分子和结构表征用作疫苗抗原incervarix TM，AS04辅助HPV-16和-18宫颈癌疫苗

代理获取

本网站仅为用户提供外文OA文献查询和代理获取服务，本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文，但由于OA文献来源多样且变更频繁，仍可能出现获取不到、文献不完整或与标题不符等情况，如果获取不到我们将提供退款服务。请知悉。

页面导航

著录项
引文网络
相似文献
相关主题

著录项

作者
Michel Deschuyteneer; Abdelatif Elouahabi; Dominique Plainchamp; Michel Plisnier; Dominique Soete; Yvon Corazza; Laurence Lockman; Sandra Giannini; Marguerite Deschamps;
展开▼
作者单位

展开▼
年度 2010
总页数
原文格式 PDF
正文语种
中图分类

相似文献

外文文献
中文文献
专利

1. Molecular and structural characterization of the L1 virus-like particles that are used as vaccine antigens in Cervarix, the AS04-adjuvanted HPV-16 and -18 cervical cancer vaccine. [J] . Deschuyteneer M, Elouahabi A, Plainchamp D, Human vaccines . 2010,第5期

机译：L1病毒样颗粒的分子和结构表征，用作Cervarix，AS04佐剂的HPV-16和-18宫颈癌疫苗的疫苗抗原。
2. Cross-protective efficacy of HPV-16/18 AS04-adjuvanted vaccine against cervical infection and precancer caused by non-vaccine oncogenic HPV types: 4-year end-of-study analysis of the randomised, double-blind PATRICIA trial. [J] . Wheeler CM, Castellsague X, Garland SM, The lancet oncology . 2012,第1期

机译：HPV-16 / 18 AS04辅助疫苗对由非疫苗致癌HPV类型引起的宫颈感染和癌变的交叉保护功效：随机双盲PATRICIA试验的4年研究结束。
3. A review of cross-protection against oncogenic HPV by an HPV-16/18 AS04-adjuvanted cervical cancer vaccine: importance of virological and clinical endpoints and implications for mass vaccination in cervical cancer prevention. [J] . Gynecologic Oncology: An International Journal . 2008,第3Suppla1期

机译：HPV-16 / 18 AS04辅助宫颈癌疫苗对致癌性HPV的交叉保护综述：病毒学和临床终点的重要性及其对预防宫颈癌的大规模疫苗接种的意义。
4. Structural Characterization of L1 Virus-Like Particles Used as Antigens in Cervarix~(TM) , the HPV-16 and HPV-18 Vaccine against Cervical Cancer [C] . M. Deschuyteneer, A. Miseur Microscopy and microanalysis.;Microscopy and microanalysis. . -1

机译：用于宫颈癌的Cervarix〜（TM），HPV-16和HPV-18疫苗中用作抗原的L1病毒样颗粒的结构表征
5. Production and Characterization of Chimeric Human Papillomavirus L1 Virus-Like Particles for Use as a Contraceptive Vaccine [D] . Brown Jordan, Thomas. 2020

机译：嵌合人乳头瘤病毒L1病毒样颗粒的生产和表征用作避孕疫苗
6. Human Papillomavirus Type 16 (HPV-16) Virus-Like Particle L1-Specific CD8+ Cytotoxic T Lymphocytes (CTLs) Are Equally Effective as E7-Specific CD8+ CTLs in Killing Autologous HPV-16-Positive Tumor Cells in Cervical Cancer Patients: Implications for L1 Dendritic Cell-Based Therapeutic Vaccines [O] . Stefania Bellone, Karim El-Sahwi, Emiliano Cocco, 2009

机译：人乳头瘤病毒16型（HPV-16）病毒样L1特异性CD8 +细胞毒性T淋巴细胞（CTL）与E7特异性CD8 + CTL一样有效地杀死宫颈癌患者的自体HPV-16阳性肿瘤细胞：对L1的影响基于树突状细胞的治疗疫苗
7. Human Papillomavirus Type 16 (HPV-16) Virus-Like Particle L1-Specific CD8+ Cytotoxic T Lymphocytes (CTLs) Are Equally Effective as E7-Specific CD8+ CTLs in Killing Autologous HPV-16-Positive Tumor Cells in Cervical Cancer Patients: Implications for L1 Dendritic Cell-Based Therapeutic Vaccines▿ [O] . Bellone, Stefania, El-Sahwi, Karim, Cocco, Emiliano, 2009

机译：人乳头瘤病毒16型（HPV-16）病毒样L1特异性CD8 +细胞毒性T淋巴细胞（CTL）与E7特异性CD8 + CTL一样有效地杀死宫颈癌患者的自体HPV-16阳性肿瘤细胞：对L1的影响基于树突状细胞的治疗性疫苗▿

Molecular and structural characterization of the L1 virus-like particles that are used as vaccine antigens inCervarix™, the AS04-adjuvanted HPV-16 and -18 cervical cancer vaccine

著录项

引文网络

相似文献

相关主题

期刊订阅